Interestingly, epidermal growth factor receptor (EGFR) inhibition in human glioblastoma cells results in a reduction of telomerase activity and telomere shortening and is associated with slower tumor progression in mice in a dose-dependent manner [54]. This evidence concerns the gene EGFR and neoplasm.